Erectile Dysfunction Drugs Market (Updated Version Available)

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.
The global Erectile Dysfunction Drugs market is valued at 5042.6 million US$ in 2018 and will reach 6583.3 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Erectile Dysfunction Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Erectile Dysfunction Drugs in key regions like North America, Europe, China, South Korea and Israel, focuses on the consumption of Erectile Dysfunction Drugs in these regions.
This research report categorizes the global Erectile Dysfunction Drugs market by top players/brands, region, type and end user. This report also studies the global Erectile Dysfunction Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.

Erectile Dysfunction Drugs market size by Type
Sildenafil
Tadalafil
Others

In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.

Erectile Dysfunction Drugs market size by Applications
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)

In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Erectile Dysfunction Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Erectile Dysfunction Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Erectile Dysfunction Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Erectile Dysfunction Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Erectile Dysfunction Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Pill). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Erectile Dysfunction Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.